This compound is a pharmaceutical intermediate featuring a tert-butoxycarbonyl-protected amino group and a hydroxyl group on a cyclohexane ring with defined cis stereochemistry. It is primarily used as a building block in the synthesis of more complex pharmaceutical compounds.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 224309-64-2
CIS-4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANOL
Pharmaceutical intermediate for synthesis
CIS-4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANOL
Pharmaceutical intermediate for API synthesis
Ethyl 4-amino-2,2-difluorobutanoate hydrochloride
pharmaceutical intermediate for API synthesis
4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate
pharmaceutical intermediate
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-
Pharmaceutical intermediate for deucravacitinib synthesis
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
Pharmaceutical intermediate for deucravacitinib
tert-butyl N-(4-hydroxycyclohexyl)carbamate
DQARDWKWPIRJEH-UHFFFAOYSA-N
CC(C)(C)OC(=O)NC1CCC(CC1)O